Portfolio Update
- ShriRam Pistons(26%)
- CEInsys(22%)
- Frontier Springs(21%)
- CreditAccess(10%)
- Manorama(10%)
- KAKA Industries(5%)
- SKM Egg(4%)
- Ganesh BenzoPlast(2%)
Sold Everything else. To Buy a Property.
Portfolio Update
Sold Everything else. To Buy a Property.
I have been tracking it since IPO. Invested very low levels. In my view, the 1000 Crore target will be achieved earlier than guided. The China plus advantage may be a positive surprise.
Does anyone has more insight on Shardul Securities. It Q.o.Q numbers are tremendous and reserves has been rising. Book value is still comparable with the current price and P/E is less than 4.
Although the stock has been cycle of upper circuit and lower circuit. Is it operator play? Would really appreciate if anyone can share their expertise. Thanks !
izmo Ltd. Launches izmo Micro: India’s Leading System-in-Package (SiP)
Manufacturing Facility, Now OperaƟonal in Bangalore.
Entering into Semiconductor space
After reading the AR 2023-24, i found some aspects worth discussing, which i will be sharing in subsequent posts.
Still how they will reach the PAT of INR 4000 by FY’27 is not clear. The Path is a bit unclear.
Even if we take NIMs of 4 percent on book assets of 40k cr – INR 1,600
plus 1 percent on total AUM of 1 lacs cr – INR 1000
plus 0.5 percent processing fee on incremental disbursal – say 150-200 crs. (On disbursement of 30k crs)
Revenue sum barely reaches 3000 crs and on top of that you have Opex and credit costs.
In all scenarios it ends up in range of 1800-2200 crs.
Is there any other fee or income that comes in case of colending?
Do they get some additional revenue share if they are originating, maintaining and collecting from the customers? Logically, they should be getting some additional share for ops purpose.
Also, in my knowledge, when you give FLDG to the colender then you tend to get higher share in the arrangement (at tandem your credit risks shoots up).
Can someone help to solve this piece of puzzle.
@Ballaji_Vijayan @Mihir_iitr @Vineet_Bhatia and others.
Disc: tracking position taken
@joinjp2003 @amit151190 and others what’s your take on Star Health. They have highest market share in Retail health insurance space and have been churning good PAT with guidance of 3x PAT in next 4 years with doubling of Premium.
How shall we compare the PB fintech with a traditional insurance company like Star Health from the valuation perspective?
Health Insurance sector shall explode in India in coming time (the process has already begun). This is the accumulation stage of the long term story thats still panning out.
Thanks!
Disc: Invested in Star Health and PB fintech
Recently, SMIORE has expanded its operations to include ferroalloy production, coke manufacturing, and power generation. They’ve also integrated downstream, aiming to become a more vertically integrated player in the steel and energy sectors. This diversification helps mitigate some of the cyclicality associated with raw material markets like manganese and iron ore.
Let’s break down the significance of each operation:
The synergy
Hi @araman,
How to refresh the database with the latest data?
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!